Google DeepMind launched AlphaGenome, an AI tool that helps identify genetic mutations driving disease.
The system predicts how DNA changes disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters simultaneously.
Researchers trained it using public human and mouse genetics databases.
Scientists believe the tool could accelerate cancer research and gene therapy development.
Experts say it marks a major advance in understanding the genome’s non-coding regions.
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment
